<DOC>
	<DOCNO>NCT02111993</DOCNO>
	<brief_summary>The objective study evaluate myocardial injury , , quantify cardiac marker ( Troponin-T ) defibrillation threshold ( DFT ) test implantation implantable cardioverter defibrillator ( ICDs ) use upper limit vulnerability ( ULV ) method vs. standard defibrillation threshold method .</brief_summary>
	<brief_title>Evaluating Myocardial Injury Defibrillation Threshold Testing Methods ICD Implantation</brief_title>
	<detailed_description>This prospective , randomize ( 1:1 DFT v ULV testing ) , control clinical research trial . Patients undergo ICD implant device change candidate study . Medical record patient screen prior enrollment ensure eligibility study . Each patient candidate agree participate study undergo standard care pre-procedure evaluation include complete medical history evaluation , complete physical examination routine laboratory test include chemistry panel , hematology panel , coagulation panel , 12-lead electrocardiogram , urine pregnancy test ( females child-bearing age ) . A candidate patient randomly assign either standard DFT test method group ULV test method group . For standard DFT test group , per routine standard care , patient admit hospital . The study require pre-procedure blood test 3 ml Troponin-T ( TnT ) drawn prior DFT test . The blood sample send University California , San Diego ( UCSD ) central laboratory processing . The patient undergo schedule ICD implant procedure standard fashion . The standard defibrillation threshold test perform use low energy shock deliver T-wave induce ventricular fibrillation ( VF ) . If VF induce , first shock 25J . If success , wait 5 minute repeat process . If 2nd shock yield success , DFT test complete 10J safety margin achieve ( device shock energy set 35J clinically indicate determine treat Cardiac Electrophysiologist ) . A back-up external defibrillator always immediately available case transvenous shock fail . Blood pressure monitor immediately shock . After 4 hour , 8 hour 16 hour post DFT testing , blood sample ( 3 ml Troponin-T ) drawn send UCSD central laboratory processing . For ULV test group , per routine standard care , patient admit hospital . The study require pre-procedure blood test ( 3 ml Troponin-T. ) drawn prior ULV test . The blood sample send UCSD central laboratory processing . The patient undergo schedule ICD implant procedure standard clinical care . The ULV testing perform follow : single coil device , 18J shock deliver 0msec , +20 msec , -20msec -40msec measure peak T-wave ; dual coil device , 18J shock deliver 0msec , -20msec , +20msec , +40msec measure peak T-wave . If VF induce mentioned shock , ULV consider 18J ICD implant first shock strength set 30 joule clinically indicate determined treat Cardiac Electrophysiologist . If VF induce , 25J rescue shock deliver standard successful , device program maximum output 35 joule clinically indicate determined treat Cardiac Electrophysiologist . Blood pressure monitor immediately shock . After 4 hour , 8 hour 16 hour post ULV testing , blood sample ( 3 ml Troponin-T ) drawn send UCSD central laboratory processing . Other blood test Troponin-T , change routine post-operative management . Patients follow every three month , standard management patient ICDs . The TnT blood draw 4-hour , 8-hour 16-hour post implantation require long hospital stay standard patient undergo ICD implantation . The result Troponin-T measurement study patient review cardiac electrophysiology ( EP ) research staff . If myocardial injury note ( TnT value &gt; 0.1 per current assay UCSD laboratory ) , patient monitor deem clinically necessary treat Cardiac Electrophysiologist , include possible repeat TnT measurement evaluation myocardial infarction . We follow standard care management myocardial injury recommend American Heart Association American College Cardiology . Elevated TnT measurement may delay hospitalization , determine clinically necessary . If repeat TnT measurement &lt; 0.1 , myocardial injury unlikely positive TnT value likely due DFT shock .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Patients eligible receive ICD implant change . Patients single dual coil right ventricle ( RV ) defibrillation lead locate RV apex . Patients great 18 year age . Patients willing able give inform consent . Patients insurance may cover additional hospital stay myocardial injury result test Patients medical condition would limit study participation . Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Defibrillation test</keyword>
	<keyword>Upper Limit Vulnerability</keyword>
	<keyword>ULV</keyword>
	<keyword>DFT</keyword>
	<keyword>ICD</keyword>
	<keyword>implantable cardioverter defibrillator</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>cardiac arrhythmia</keyword>
	<keyword>cardiac device test</keyword>
</DOC>